Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
News Log
Topics
Nordics
AI Docs
Soft Funding
Investors
AIDAVA
Research Wiki
Search
Search
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
PHKG Business Models & Market
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Special pages
Page information
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
__NOTOC__ Business models, value propositions, and market analysis for Personal Health Knowledge Graphs, health data curation, and the AIDAVA-adjacent ecosystem. Where is the money? Where will it be in 5 years? == Market Size (Current) == {| class="wikitable" |- ! Market !! Size !! Source |- | Healthcare Data Monetization || $1.76B (growing) || openPR<ref>openPR (2025): "Healthcare Data Monetization Market Set to Reach $1.76 Billion" β https://www.openpr.com</ref> |- | Knowledge Graph Market || $6.9B by 2030 || MarketsandMarkets<ref>MarketsandMarkets (2025): "Knowledge Graph Market worth $6,938.4 million by 2030" β https://www.marketsandmarkets.com</ref> |- | Clinical Analytics || Growing 2025-2030 || MarketsandMarkets<ref>MarketsandMarkets (2025): "Clinical Analytics Market Report 2025-2030"</ref> |- | Europe Healthcare Analytics || Growing 2025-2030 || MarketsandMarkets |- | Genomic Data Platforms || Growing through 2034 || Fortune Business Insights<ref>Fortune Business Insights (2025): "Genomic Data Platforms Market Size" β https://www.fortunebusinessinsights.com</ref> |- | Global Digital Health || Multi-billion, growing 18%+ CAGR || Various |} == Existing Business Models == === 1. Health Data Curation as a Service === '''What:''' Curate, clean, and harmonize clinical data from heterogeneous sources into standardized formats (FHIR, OMOP, SNOMED). '''Who does this today:''' * [[AIDAVA]] β research prototype, not yet commercial * Datavant β US, de-identification and data linking ($7B valuation 2021) * Verana Health β ophthalmology data curation from EHR * TriNetX β federated clinical data network for trials * IQVIA β clinical data services (public, $35B market cap) * Snowflake β health data cloud platform * VEIL.AI β health data quality platform<ref>Snowflake (2025): "Startup Spotlight: VEIL.AI for Healthcare" β https://www.snowflake.com</ref> '''Revenue model:''' Per-record curation fees, subscription platform fees, or data-as-a-service '''Value:''' Hospitals spend 20-40% of IT budgets on data integration. Automating 45% (AIDAVA's current rate) saves millions per hospital. '''EU-specific opportunity:''' EHDS will require hospitals to make data available in standardized formats by 2029-2030. Hospitals need curation tools NOW. === 2. Health Data Intermediary Platform === '''What:''' Platform enabling patients to control, curate, and share their health data. Regulated under EU Data Governance Act. '''Who does this today:''' * [[MIDATA Cooperative]] β Swiss data cooperative, patient-owned health data * [[Egnosis]] β Romanian health data intermediary * MIDATA model: patients store data, consent to sharing, receive value * Solid Project (Tim Berners-Lee) β personal data pods '''Revenue model:''' * B2B: Hospitals pay for patient data access for research (anonymized) * B2B2C: Pharmaceutical companies pay for curated patient cohorts * Platform fees: % of data sharing transactions * Subscription: patients pay for data management '''Value:''' By 2030, EU citizens will control their data (EHDS vision). Intermediaries facilitate this. Market for consent management alone is growing rapidly.<ref>Nature (2025): "A user-driven consent platform for health data sharing in digital health applications" β https://www.nature.com</ref> '''Regulatory tailwind:''' EU Data Governance Act (2022), EHDS regulation (2024), EU AI Act β all require trustworthy data intermediaries. === 3. Knowledge Graph Infrastructure === '''What:''' Graph databases and semantic platforms for health data integration. '''Who does this today:''' * [[Ontotext]] (GraphDB) β enterprise knowledge graphs, health vertical * Neo4j β general graph DB, healthcare growing * Franz Inc. (AllegroGraph) β semantic graph DB for life sciences * Stardog β knowledge graph platform for pharma * Amazon Neptune β managed graph DB * TigerGraph β scalable graph analytics '''Revenue model:''' License + support, cloud consumption, managed service '''Value:''' $6.9B market by 2030. Health is fastest-growing vertical. === 4. FHIR/Interoperability Services === '''What:''' Build, deploy, and manage FHIR APIs and health data exchange. '''Who does this today:''' * Firely (FHIR server) β Dutch, HL7 FHIR standard authors * Smile CDR β Canadian FHIR platform * Google Cloud Healthcare API β FHIR-native * Microsoft Azure Health Data Services β FHIR + DICOM * 1upHealth β US FHIR platform '''Revenue model:''' API calls (consumption), platform subscription, implementation services '''Value:''' FHIR is mandatory in US (CMS Final Rule), becoming mandatory in EU (EHDS). Every hospital, insurer, and health app needs FHIR connectivity. === 5. Clinical Data for Research/Pharma === '''What:''' Curated, de-identified clinical data sold to pharmaceutical companies for drug development, clinical trial design, real-world evidence. '''Who does this today:''' * IQVIA β world's largest health data company * Flatiron Health (Roche) β oncology real-world data * TriNetX β federated clinical trial network * Tempus β genomic + clinical data for cancer * UK Biobank β research data (500K participants) * OHDSI β open-source observational data network '''Revenue model:''' Per-dataset licensing, subscription access, per-query pricing, revenue share on drug approvals '''Value:''' Pharmaceutical companies pay $50K-$500K+ per curated dataset. A single well-curated oncology dataset can be worth millions. Data quality directly impacts drug approval success. === 6. Patient Engagement / PHR === '''What:''' Personal health record platforms that engage patients in maintaining their own data. '''Who does this today:''' * Apple Health Records β iPhone-based PHR * Google Health β PHR + search * Epic MyChart β dominant US patient portal * Patientory β blockchain-based PHR * 1upHealth β patient-facing FHIR apps '''Revenue model:''' Freemium (patient), B2B (hospital licenses), B2B2C (pharma access to consenting patients) '''Value:''' Patient-engaged data is 3-5x more complete than EHR-only data. More data = better research = better outcomes. == Emerging Business Models (2026-2030) == === 7. EHDS Compliance Tooling === '''What:''' Tools helping hospitals comply with EHDS data availability requirements. '''Opportunity:''' Every EU hospital must make health data available in standardized formats by 2029-2030. This is a MASSIVE compliance market β similar to GDPR but for health data. '''Revenue model:''' Compliance software subscriptions, implementation consulting, ongoing data quality monitoring '''Size estimate:''' 27 EU countries x thousands of hospitals x EUR 50K-500K per hospital = multi-billion market '''Timing:''' EHDS implementation timeline: * 2025-2026: National transposition * 2027-2029: Infrastructure build-out * 2029-2030: Mandatory data availability * Startups building NOW will have 2-3 year head start === 8. Health Data Quality Labels === '''What:''' Quality certification for health datasets β like organic labels for food. '''Who's building this:''' * QUANTUM project (EU-funded, i-HD participating) β "data quality and utility label for EHDS"<ref>i-hd.eu/projects</ref> * Swiss Personalized Health Network β FAIRification of health data<ref>Nature (2025): "FAIRification of health-related data using semantic web technologies" β https://www.nature.com</ref> '''Revenue model:''' Certification fees, quality monitoring subscriptions, insurance/risk pricing '''Value:''' High-quality data sells for 5-10x premium. Quality labels enable market pricing. === 9. Health Data Cooperatives === '''What:''' Patient-owned cooperatives that pool and monetize member health data. '''Who's doing this:''' * [[MIDATA Cooperative]] β Swiss model, patients as cooperative members * DECODE (Barcelona) β data sovereignty experiment * Data For Patients ([[DFP Research]]) β AIDAVA partner '''Revenue model:''' Members share in revenue from data sales. Cooperative takes % for platform costs. '''Value:''' Aligned incentives β patients benefit directly from sharing. Addresses trust gap in health data. === 10. PHKG as Infrastructure === '''What:''' Personal Health Knowledge Graph as underlying infrastructure for ALL health applications. '''Analogy:''' PHKG is to health data what the relational database was to business data in the 1980s. Once the infrastructure exists, thousands of applications build on top. '''Potential applications:''' * Clinical decision support (doctor sees complete patient history) * Insurance underwriting (automated, consent-based) * Drug interaction checking (cross-system) * Preventive health (pattern detection over years) * Clinical trial matching (automated eligibility) * Population health (anonymized aggregate analytics) * Personalized medicine (treatment based on full history) '''Revenue model:''' Platform fee per patient per year (like cloud infrastructure) == Five-Year Outlook (2026-2031) == === 2026-2027: Foundation === * EHDS regulation transposed into national law * First EHDS compliance tools emerge * AIDAVA delivers G2 prototype (project ends Aug 2026) * Knowledge graph market hits $5B+ * Healthcare data monetization exceeds $2B * Patient data intermediaries get regulated framework === 2027-2028: Build-out === * Hospitals begin EHDS infrastructure investment * First commercial PHKG platforms launch * FHIR becomes universal health data language * Health data cooperatives gain traction (MIDATA model scales) * AI-curated clinical datasets become standard for pharma R&D * Quality labels for health data established === 2028-2029: Acceleration === * EHDS compliance deadlines approach β panic buying of tools * PHKG infrastructure enables new applications (trial matching, predictive health) * Patient-engaged data platforms reach critical mass * Health data marketplaces operate at scale * First health data cooperatives pay dividends to members * Big tech (Google, Apple, Microsoft) deepen health data positions === 2029-2030: Mandate === * EHDS mandatory data availability kicks in * Every EU hospital must provide standardized data * PHKG becomes standard infrastructure (like EHR in 2010s) * Clinical data curation is largely automated (80%+ vs AIDAVA's 45% today) * Health data quality determines research competitiveness * Patient data sovereignty becomes norm === 2030-2031: Maturity === * Health data interoperability solved in EU * PHKG infrastructure enables precision medicine at scale * Data-driven preventive health reduces healthcare costs 10-20% * Health data cooperatives compete with traditional data brokers * Personalized health management based on complete longitudinal records * Research breakthroughs from previously siloed data == Competitive Landscape == '''Who's positioned to win:''' {| class="wikitable" |- ! Category !! Leaders !! Challengers !! Opportunity |- | Data Curation || IQVIA, Datavant || AIDAVA (research), VEIL.AI || EU-specific, EHDS-compliant curation |- | Knowledge Graphs || Neo4j, Ontotext || Stardog, TigerGraph || Health-specific vertical KG platform |- | Interoperability || Google, Microsoft, Epic || Firely, Smile CDR || EU-focused, small hospital segment |- | Data Intermediaries || MIDATA (niche) || Egnosis, DFP Research || First to scale in EU wins |- | Clinical Data || IQVIA, Flatiron || TriNetX, OHDSI || EU data with GDPR/EHDS compliance |- | PHR || Apple, Epic || None dominant in EU || EU-compliant, patient-owned PHR |} == Implications for a Startup == If building in this space today: # '''Start with EHDS compliance''' β hospitals will pay for this NOW # '''Use knowledge graphs''' β they're the right architecture for longitudinal data # '''Build for the intermediary model''' β Data Governance Act creates this category # '''Focus on EU''' β regulatory tailwind is massive, US market already crowded # '''Automate curation''' β AIDAVA proved 45% is possible, target 80%+ # '''Engage patients''' β they become data stewards under EHDS # '''Quality is the moat''' β better data quality = premium pricing == See Also == * [[AIDAVA]] * [[AIDAVA Documents]] * [[Knowledge Graphs in Health]] * [[Interoperability]] * [[Soft Funding Norway]] * [[EU Regulation]] [[Category:Topic]]
Summary:
Please note that all contributions to Research Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Research Wiki:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Toggle limited content width